53 related articles for article (PubMed ID: 9769238)
1. Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk.
Lemire I; Allen BG; Rindt H; Hebert TE
J Mol Cell Cardiol; 1998 Sep; 30(9):1827-39. PubMed ID: 9769238
[TBL] [Abstract][Full Text] [Related]
2. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
4. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
6. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profile of neurodegeneration induced by alpha1B-adrenergic receptor overactivity: NMDA/GABAA dysregulation and apoptosis.
Yun J; Gaivin RJ; McCune DF; Boongird A; Papay RS; Ying Z; Gonzalez-Cabrera PJ; Najm I; Perez DM
Brain; 2003 Dec; 126(Pt 12):2667-81. PubMed ID: 12937073
[TBL] [Abstract][Full Text] [Related]
8. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.
Tepe NM; Lorenz JN; Yatani A; Dash R; Kranias EG; Dorn GW; Liggett SB
Biochemistry; 1999 Dec; 38(50):16706-13. PubMed ID: 10600134
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
10. Chronic direct stimulation of adenylyl cyclase induces cardiac desensitization to catecholamine and beta-adrenergic receptor downregulation in rabbits.
Takagi I; Nejima J; Kiuchi K; Takagi G; Takano T
J Cardiovasc Pharmacol; 2006 Nov; 48(5):223-30. PubMed ID: 17110804
[TBL] [Abstract][Full Text] [Related]
11. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
[TBL] [Abstract][Full Text] [Related]
12. Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation.
Okumura S; Kawabe J; Yatani A; Takagi G; Lee MC; Hong C; Liu J; Takagi I; Sadoshima J; Vatner DE; Vatner SF; Ishikawa Y
Circ Res; 2003 Aug; 93(4):364-71. PubMed ID: 12869393
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC
Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551
[TBL] [Abstract][Full Text] [Related]
14. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
15. Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression.
Andressen KW; Norum JH; Levy FO; Krobert KA
Mol Pharmacol; 2006 Jan; 69(1):207-15. PubMed ID: 16189297
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
17. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.
Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH
Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level.
Alloatti G; Marcantoni A; Levi R; Gallo MP; Del Sorbo L; Patrucco E; Barberis L; Malan D; Azzolino O; Wymann M; Hirsch E; Montrucchio G
FEBS Lett; 2005 Jan; 579(1):133-40. PubMed ID: 15620702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
